Skip to main content
. Author manuscript; available in PMC: 2011 May 3.
Published in final edited form as: Ann Surg. 2011 Feb;253(2):328–335. doi: 10.1097/SLA.0b013e3181fd271c

FIGURE 2.

FIGURE 2

A, Disease-free survival after treatment with allogeneic, irradiated, GM-CSF secreting pancreatic tumor cells as immunotherapy. The survival function is plotted with 95% confidence intervals. The median is denoted with a solid line. B, Overall survival after treatment with allogeneic, irradiated, GM-CSF secreting pancreatic tumor cells as immunotherapy. The survival function is plotted with 95% confidence intervals. The median is denoted with a solid line.